Latest Conference Articles
The OncLive® Conference page includes a listing of all conferences covered by OncLive®, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.
Post-Oophorectomy Hormone Replacement Therapy Safe for BRCA1/2 Mutation Carriers
June 7th 2011, 9:42am
Women who present with BRCA1 and BRCA2 mutation face an increased risk of breast and ovarian cancer.
Dr. Infante Talks About BRAF Mutation Testing
June 7th 2011, 9:22am
Dr. Infante from Sarah Cannon Research Institute Talks About BRAF Mutation Testing
PTEN Expression Does Not Diminish Trastuzumab Effectiveness
June 7th 2011, 8:08am
Phosphatase and tensin homolog (PTEN)-positive breast cancer can be treated with trastuzumab (Herceptin) as effectively as PTEN-negative breast cancer
ASCO 2011 Annual Meeting Picture Slideshow Day Four
June 7th 2011, 7:31am
American Society of Clinical Oncology 2011 Annual Meeting Picture Slideshow Day Four
Axitinib Outperforms Sorafenib in Renal Cell Carcinoma Trial
June 7th 2011, 6:04am
Axitinib demonstrated significantly better progression-free survival (PFS) compared with sorafenib
Deciphering the Challenge of the Genomic Era in Breast Cancer
June 6th 2011, 10:09am
Luminal A genetic signature in node-negative, estrogen receptor- (ER-) positive breast cancer predicts a very high disease-free survival rate
Rethinking Initial Management of Patients With Brain Metastasis and HER2 Breast Cancer
June 6th 2011, 9:47am
Lapatinib and capecitabine is a reasonable approach in a well-informed patient with brain metastasis and HER2+ breast cancer
Two Studies Herald New Era in Melanoma Therapy
June 6th 2011, 7:07am
New treatment approaches that improve overall survival for patients with late-stage melanoma spotlighted
Three-Year Imatinib Regimen Delivers Optimal GIST Treatment
June 6th 2011, 6:47am
3 years of treatment with imatinib (Gleevec) after surgery in patients with high-risk GIST improved overall and recurrence-free survival
Pemetrexed Maintenance Improves Progression-Free Survival in Patients With NSCLC
June 6th 2011, 6:37am
Continuation maintenance with pemetrexed (Alimta) improves progression-free survival in patients with advanced nonsquamous non–small cell lung cancer
Dr. Wolchok Describes the Immunotherapy Ipilimumab
June 6th 2011, 6:26am
Dr. Wolchok from Memorial Sloan-Kettering Cancer Center Describes the Immunotherapy Ipilimumab
Dr. Kris on the Use of Genetic Testing in Lung Cancer
June 6th 2011, 5:38am
Dr. Kris From Memorial Sloan-Kettering Cancer Center on the Use of Genetic Testing in Lung Cancer
MEK and BRAF Therapy Combo Promising for Advanced Melanoma
June 5th 2011, 2:10pm
The combination of the MEK inhibitor GSK212 and the oral BRAF inhibitor GSK436 resulted in anti-tumor activity in patients with advanced melanoma
Dr. Virgo on Survivorship Care Training & Policies
June 5th 2011, 12:15pm
Dr. Katherine Virgo from the American Cancer Society Discusses Survivorship Care Training & Policies
Dr. Hoos on the Patients That Respond to Ipilimumab
June 5th 2011, 11:48am
Dr. Axel Hoos from Bristol Myers-Squib on the Patients That Respond to Ipilimumab
Dr. Chapman Describes the Side Effects of Vemurafenib
June 5th 2011, 11:43am
Dr. Paul Chapman from Memorial Sloan-Kettering Cancer Center Describes the Side Effects of Vemurafenib
Dr. Tsimberidou Discusses Improving Care
June 5th 2011, 11:23am
Apostolia M. Tsimberidou, MD, PhD, from MD Anderson Cancer Center discusses improving cancer care.
Dr. Cella on Patient Assessment Reference Scores
June 5th 2011, 11:07am
Dr. Cella from Northwestern University Feinberg School of Medicine on Patient Assessment Reference Scores
Genetic Testing Delivers Personalized Lung Cancer Therapy
June 5th 2011, 10:24am
Taking a page from breast cancer treatment, clinicians managing lung cancer patients can now detect mutations that drive the development of lung cancer
NKTR-102 Shows Promise in Phase II Trial
June 5th 2011, 9:58am
Metastatic breast cancer patients with demonstrated disease progression after taxane therapy face an uphill battle in fighting their disease.